AIMD - Ainos, Inc. Stock Price, Fair Value and News

1.04USD0.00 (0.00%)Market Closed

Market Summary

USD1.040.00

Market Closed

0.00%

AIMD Stock Price

View Fullscreen

AIMD RSI Chart

AIMD Valuation

Market Cap

4.9M

Price/Earnings (Trailing)

-0.35

Price/Sales (Trailing)

39.84

EV/EBITDA

-0.32

Price/Free Cashflow

-1.02

AIMD Price/Sales (Trailing)

AIMD Profitability

Operating Margin

-207.79%

EBT Margin

-11810.32%

Return on Equity

-56.33%

Return on Assets

-43.25%

Free Cashflow Yield

-98.41%

AIMD Fundamentals

AIMD Revenue

Revenue (TTM)

122.1K

Rev. Growth (Yr)

-98.08%

Rev. Growth (Qtr)

-18.72%

AIMD Earnings

Earnings (TTM)

-13.8M

Earnings Growth (Yr)

-178.01%

Earnings Growth (Qtr)

-99.09%

Breaking Down AIMD Revenue

Last 7 days

1.0%

Last 30 days

-15.4%

Last 90 days

15.6%

How does AIMD drawdown profile look like?

AIMD Financial Health

Current Ratio

1.85

AIMD Investor Care

Shares Dilution (1Y)

1.40%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	2.7M	1.8M	971.5K	122.1K
2022	679.6K	1.1M	2.5M	3.5M
2021	161.1K	305.6K	450.1K	594.6K
2020	22.9K	22.7K	18.1K	16.6K
2019	25.2K	25.6K	15.4K	11.7K
2018	307.5K	57.3K	72.2K	77.7K
2017	0	195.9K	223.4K	250.9K
2016	113.4K	140.9K	168.4K	0
2015	0	0	0	85.9K
2011	18.5K	31.8K	45.1K	58.4K
2010	0	0	0	5.2K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Ainos, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Feb 16, 2024	sung meng lin	acquired	912	0.8693	1,050	chief financial officer
Feb 16, 2024	lin lawrence k	acquired	312	0.8693	360	e.v.p. of operations
Feb 16, 2024	tsai chun-hsien	acquired	22,688	0.8693	26,100	ceo, president, chairman
Feb 16, 2024	tsai chung-jung	acquired	14,082	0.8693	16,200	-
Feb 16, 2024	lee ting-chuan	acquired	12,517	0.8693	14,400	-
Jan 31, 2024	wei pao-sheng	acquired	1,378	0.94	1,466	-
Jan 31, 2024	tsai chung-yi	acquired	1,378	0.94	1,466	-
Jan 31, 2024	chiang yao-chung	acquired	1,378	0.94	1,466	-
Jan 31, 2024	chang wen-han	acquired	1,378	0.94	1,466	-
Nov 24, 2023	lin lawrence k	acquired	6,000	0.6	10,000	e.v.p. of operations

Which funds bought or sold AIMD recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 05, 2024	CWM, LLC	unchanged	-	-	-	-%
Feb 26, 2024	Virtu Financial LLC	sold off	-100	-7,000	-	-%
Feb 14, 2024	STATE STREET CORP	sold off	-100	-18,724	-	-%
Feb 14, 2024	CVI Holdings, LLC	unchanged	-	-9,628	17,325	0.04%
Feb 14, 2024	BOOTHBAY FUND MANAGEMENT, LLC	unchanged	-	35,750	51,250	-%
Feb 14, 2024	Anson Funds Management LP	reduced	-80.00	-10,500	20,500	-%
Feb 14, 2024	Hudson Bay Capital Management LP	reduced	-60.28	-18,441	6,323	-%
Feb 14, 2024	CITADEL ADVISORS LLC	sold off	-100	-8,675	-	-%
Feb 14, 2024	CITADEL ADVISORS LLC	added	42.67	-868	9,594	-%
Feb 13, 2024	BlackRock Inc.	new	-	31,416	31,416	-%

Are Funds Buying or Selling AIMD?

Are funds buying AIMD calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AIMD

No. of Funds

Unveiling Ainos, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Jan 29, 2024	ainos inc	62.05%	2,938,487	SC 13D/A

Recent SEC filings of Ainos, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 16, 2024	EFFECT	EFFECT
Apr 08, 2024	S-1	Initial Public Offering
Mar 19, 2024	3	Insider Trading
Mar 19, 2024	8-K	Current Report
Mar 15, 2024	8-K	Current Report
Mar 11, 2024	SC 13D/A	13D - Major Acquisition
Mar 08, 2024	10-K	Annual Report
Mar 08, 2024	8-K	Current Report
Feb 20, 2024	4	Insider Trading
Feb 20, 2024	4	Insider Trading

Peers (Alternatives to Ainos, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	186.5B	40.1B	-4.14%	-1.72%	32.59	4.65	-8.12%	-17.45%
BDX	66.9B	19.5B	-4.72%	-10.85%	53.25	3.43	4.02%	-22.04%
ALGN	23.2B	3.9B	-2.96%	-12.43%	52.14	6.01	3.42%	23.09%
BAX	20.4B	14.8B	-3.18%	-12.72%	7.67	1.38	2.12%	209.17%
MID-CAP
HSIC	9.4B	12.3B	-0.07%	-10.32%	22.59	0.76	-2.44%	-22.68%
ATR	9.3B	3.5B	-1.98%	21.26%	32.53	2.65	4.97%	18.89%
BIO	8.1B	2.7B	-19.10%	-36.82%	-12.64	3.01	-4.68%	82.43%
XRAY	6.3B	4.0B	-6.58%	-25.82%	-47.15	1.6	1.10%	85.84%
AXNX	3.4B	366.4M	-3.44%	15.93%	-559.2	9.26	33.86%	89.83%
PDCO	2.3B	6.6B	-4.62%	-2.20%	11.94	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-14.98%	-16.46%	-1.88	0.4	7.73%	-1066.14%
ANIK	379.9M	166.7M	0.99%	-2.77%	-4.6	2.28	6.67%	-456.34%
ANGO	231.5M	324.0M	7.22%	-30.16%	-1.2	0.71	-3.19%	-337.41%
APYX	51.3M	52.3M	13.28%	-50.68%	-2.74	0.98	17.61%	19.28%
AEMD	3.9M	3.7M	-14.29%	284.62%	-0.32	1.05	5.77%	8.23%

Ainos, Inc. News

Latest updates

Ainos, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-18.7%	20.00	24.00	29.00	533	1,038	1,758	637	87.00	26.00	363	203	102	687*	192*	484*	15.00	2.00	5.00	606*	4.00	6.00
Cost Of Revenue	49.4%	131	88.00	56.00	101	578	1,176	319	41.00	10.00	104	70.00	1.00	56*	123*	292*	11.00	2.00	3.00	563*	3.00	4.00
Gross Profit	-75.8%	-111	-63.38	-27.26	-51.68	460	582	318	46.00	17.00	259	133	872*	631*	69*	192*	4.00	140*	1.00	43*	1.00	2.00
Operating Expenses	114.0%	5,590	2,612	2,289	2,461	2,586	8,404	2,262	2,129	2,312	1,443	-860	523	824	321	301	-380	370	367	455	392	488
S&GA Expenses	271.7%	3,353	902	618	762	788	6,569	627	552	178	796	860	523	824	321	300	-380	370	367	405	389	455
R&D Expenses	30.8%	2,237	1,710	1,671	1,699	1,799	1,835	1,635	1,577	1,274	647	-	-	-	-	389*	-	-	-	50.00	2.00	-
EBITDA Margin	-Infinity%	-77.03*	-	-5.70*	-3.01*	-2.30*	-1.24*	0.99*	3.39*	3.88*	0.05*	0.09*	0.16*	0.86*	-	-	-	-	-	-	-	-
Interest Expenses	13.7%	50.00	44.00	-	-	16.00	10.00	3.00	17.00	9.00	-1.71	3.00	12.00	5.00	3.00	1.00	-	176*	524*	134*	69*	274*
Income Taxes	-	800*	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings Before Taxes	-99.1%	-5,923	-2,975	-2,349	-	-3,172	-7,821	-1,954	-16.83	2,162	-1,160	-749	-11.90	-	-323	-301	-	-	-	-	-	-
EBT Margin	-603.0%	-118.10*	-16.80*	-8.40*	-4.86*	-3.68*	-3.04*	-0.87*	0.35*	0.40*	-0.02*	-0.03*	-0.06*	-0.62*	-	-	-	-	-	-	-	-
Net Income	-99.1%	-5,924	-2,975	-2,349	-2,520	-2,131	-7,821	-1,954	-2,099	-1,444	-1,160	-749	-534	-448	-323	-301	-376	-370	-366	-453	-391	-486
Net Income Margin	-998.1%	-112.77*	-10.27*	-8.14*	-5.40*	-3.98*	-5.31*	-5.98*	-8.03*	-6.54*	-6.43*	-6.73*	-9.98*	-87.58*	-75.65*	-	-	-	-	-	-	-
Free Cashflow	-Infinity%	-1,358	-	-1,223	-1,499	-564	-927	-375	-1,525	-783	19,432	169	-211	-254	-	-	-	-	-	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-6.0%	31,842	33,860	34,046	36,708	37,109	39,082	40,413	40,736	40,822	19,994	20,622	13,849	7,075	301	337	479	597	692	945	1,226	1,464
Current Assets	-18.6%	2,473	3,040	2,140	3,633	2,846	3,668	3,699	3,023	2,218	885	869	42.00	76.00	158	192	332	445	552	798	1,071	1,303
Cash Equivalents	-20.5%	1,886	2,371	1,361	1,146	1,853	2,417	1,754	1,871	1,751	707	607	9.00	22.00	84.00	173	290	409	483	723	1,046	1,277
Inventory	-22.9%	168	217	528	572	595	-	-	-	-	-	-	-	3.00	3.00	4.00	4.00	4.00	6.00	10.00	9.00	-
Net PPE	-24.5%	877	1,161	1,269	1,315	1,376	1,351	1,503	1,420	1,188	40.00	23.00	3.00	3.00	4.00	4.00	4.00	5.00	2.00	6.00	11.00	14.00
Liabilities	19.7%	7,394	6,179	3,651	4,370	2,481	2,656	34,407	32,654	30,625	2,857	2,417	1,500	1,099	1,078	881	913	753	613	705	674	734
Current Liabilities	63.1%	1,337	819	1,114	1,867	2,473	2,643	6,988	5,730	30,595	2,822	2,376	1,500	1,099	1,078	881	913	753	613	705	674	734
Shareholder's Equity	-11.7%	24,448	27,681	30,395	32,338	34,628	36,426	6,006	8,083	10,197	17,136	18,206	-	-	-	-	-	-	79.00	240	552	730
Retained Earnings	-18.5%	-37,886	-31,961	-28,985	-26,636	-24,115	-21,984	-14,162	-12,208	-10,108	-8,664	-7,504	-6,754	-6,220	-5,771	-5,448	-5,146	-4,769	-4,399	-4,033	-3,579	-3,188
Additional Paid-In Capital	4.7%	62,556	59,764	59,424	-58,965	58,905	58,492	18,943	20,247	20,204	24,369	24,287	5,055	4,961	4,586	4,495	4,308	4,208	4,076	3,876	3,736	3,527
Shares Outstanding	-76.9%	4,678	20,293	20,012	20,012	4,002	19,478	9,625	9,625	9,625	9,496	9,485	2,804	2,804	-	-	-	-	-	-	-	-
Float	-	-	-	5,220	-	3,143	-	-	-	18,258	-	-	-	3,792	-	-	-	9,139	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-84.7%	-1,372	-743	-1,151	-1,427	-620	-791	-239	-1,389	-680	-526	169	-211	-254	-	-129	-115	-130	-240	-322	-216	-311
Share Based Compensation	33.0%	432	325	137	221	259	6,076	43.00	43.00	-218	19.00	94.00	94.00	-	-	-	-	-	-	-	-	-
Cashflow From Investing	134.6%	16.00	-46.27	1.00	-72.48	35.00	-240	-288	-135	-137	-20.06	-23.28	-	-5.35	-621*	-	-	-11.06	-406*	1*	-1.64	-62.92
Cashflow From Financing	-51.1%	900	1,838	1,391	795	-	1,651	555	1,645	1,864	640	452	199	35.00	75.00	-92.84	103	67.00	-	-	-12.50	450

AIMD Income Statement

2023-12-31

Statements of Operations - USD ($)	12 Months Ended
Statements of Operations - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Statements of Operations
Revenues (including amounts of related party of $33,388 and $2,855,205 for the years ended December 31, 2023 and 2022, respectively)	$ 122,112	$ 3,519,627
Cost of revenues (including amounts of related party of $118,497 and $1,968,291 for the years ended December 31, 2023 and 2022, respectively)	(375,845)	(2,114,284)
Gross (losses) profits	(253,733)	1,405,343
Operating expenses:
Research and development expenses (including amounts of related party of $368,372 and $618,522 for the years ended December 31, 2023 and 2022, respectively)	7,317,388	6,845,964
Selling, general and administrative expenses	5,635,275	8,535,591
Total operating expenses	12,952,663	15,381,555
Loss from operating	(13,206,396)	(13,976,212)
Interest expense	(144,193)	(53,528)
Issuance cost of senior secured convertible note measured at fair value	(525,643)	0
Fair value change of senior secured convertible note	94,207	0
Other income, net	12,276	23,050
Total non-operating expenses, net	(563,353)	(30,478)
Net loss before income taxes	(13,769,749)	(14,006,690)
Provision for income taxes	800	0
Net loss	$ (13,770,549)	$ (14,006,690)
Net loss per common share - basic and diluted	$ (3.36)	$ (5.14)
Weighted-average shares used in computing net loss per common share-basic and diluted	4,098,109	2,727,458

AIMD Balance Sheet

2023-12-31

Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,885,628	$ 1,853,362
Accounts receivable (including amounts of related party of nil and $177,595 as of December 31 2023 and 2022, respectively)	455	201,546
Inventory, net	167,593	595,222
Other current assets	419,521	195,787
Total current assets	2,473,197	2,845,917
Intangible assets, net	28,283,208	32,806,738
Property and equipment, net	876,572	1,375,676
Other assets	208,827	80,683
Total assets	31,841,804	37,109,014
Contract liabilities	112,555	0
Convertible notes payable, related party	0	376,526
Other notes payable, related party	42,000	884,000
Accrued expenses and other current liabilities	1,182,283	1,212,386
Total current liabilities	1,336,838	2,472,912
Senior secured convertible notes measured at fair value	2,651,556	0
Convertible notes payable - noncurrent (including amounts of related party of $2,000,000 and nil as of December 31, 2023 and 2022, respectively)	3,000,000	0
Other notes payable, related party - noncurrent	270,000	0
Other long-term liabilities	135,829	8,096
Total liabilities	7,394,223	2,481,008
Stockholders' equity:
Preferred stock, $0.01 par value; 50,000,000 shares and 10,000,000 shares authorized as of December 31, 2023 and 2022, respectively; none issued and outstanding	0	0
Common stock, $0.01 par value; 300,000,000 shares authorized as of December 31, 2023 and 2022; 4,677,787 shares and 4,002,320 shares issued and outstanding as of December 31, 2023 and 2022, respectively	46,778	40,023
Common stock to be issued, 162,337 shares and nil as of December 31, 2023 and 2022, respectively	1,623	0
Additional paid-in capital	62,555,808	58,905,242
Accumulated deficit	(37,886,155)	(24,115,606)
Accumulated other comprehensive loss - translation adjustment	(270,473)	(201,653)
Total stockholders' equity	24,447,581	34,628,006
Total liabilities and stockholders' equity	$ 31,841,804	$ 37,109,014

About Ainos, Inc.

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

CEO	Mr. Chun-Hsien Tsai
WEBSITE	ainos.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	43

Ainos, Inc. Frequently Asked Questions

What is the ticker symbol for Ainos, Inc.? What does AIMD stand for in stocks?

AIMD is the stock ticker symbol of Ainos, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Ainos, Inc. (AIMD)?

As of Thu Apr 25 2024, market cap of Ainos, Inc. is 4.86 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AIMD stock?

You can check AIMD's fair value in chart for subscribers.

What is the fair value of AIMD stock?

You can check AIMD's fair value in chart for subscribers. The fair value of Ainos, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Ainos, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AIMD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Ainos, Inc. a good stock to buy?

The fair value guage provides a quick view whether AIMD is over valued or under valued. Whether Ainos, Inc. is cheap or expensive depends on the assumptions which impact Ainos, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AIMD.

What is Ainos, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 25 2024, AIMD's PE ratio (Price to Earnings) is -0.35 and Price to Sales (PS) ratio is 39.84. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AIMD PE ratio will change depending on the future growth rate expectations of investors.